Pharmacokinetic Study to Determine Time to Steady-state
NCT00911586
·
clinicaltrials.gov ↗
PHASE2
Phase
COMPLETED
Status
15
Enrollment
INDUSTRY
Sponsor class
Conditions
Male Hypogonadism
Primary Hypogonadism
Secondary Hypogonadism
Interventions
DRUG:
Testosterone undecanoate
Sponsor
Clarus Therapeutics, Inc.